SIMILAR PATTERNS OF AMINO ACIDS FOR 3VAW_A_FK5A114

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aso ASCORBATE OXIDASE

(Cucurbita pepo)
PF00394
(Cu-oxidase)
PF07731
(Cu-oxidase_2)
PF07732
(Cu-oxidase_3)
5 ASP A 253
ARG A 322
PHE A 326
VAL A 238
ILE A 231
None
1.37A 3vawA-1asoA:
undetectable
3vawA-1asoA:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fd9 PROTEIN (MACROPHAGE
INFECTIVITY
POTENTIATOR PROTEIN)


(Legionella
pneumophila)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
6 PHE A 153
ILE A 159
TRP A 162
TYR A 185
ILE A 194
PHE A 202
None
1.14A 3vawA-1fd9A:
17.5
3vawA-1fd9A:
29.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fd9 PROTEIN (MACROPHAGE
INFECTIVITY
POTENTIATOR PROTEIN)


(Legionella
pneumophila)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
8 TYR A 131
ASP A 142
VAL A 158
ILE A 159
TRP A 162
TYR A 185
ILE A 194
PHE A 202
None
0.59A 3vawA-1fd9A:
17.5
3vawA-1fd9A:
29.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fkk FK506 BINDING
PROTEIN


(Bos taurus)
PF00254
(FKBP_C)
10 TYR A  26
ASP A  37
ARG A  42
PHE A  46
VAL A  55
ILE A  56
TRP A  59
TYR A  82
ILE A  91
PHE A  99
None
0.50A 3vawA-1fkkA:
18.0
3vawA-1fkkA:
32.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hxj BETA-GLUCOSIDASE

(Zea mays)
PF00232
(Glyco_hydro_1)
5 TYR A 163
PHE A 151
VAL A 140
TRP A  96
PHE A 166
None
1.33A 3vawA-1hxjA:
undetectable
3vawA-1hxjA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i4s RIBONUCLEASE III

(Aquifex
aeolicus)
PF14622
(Ribonucleas_3_3)
5 ASP A 138
PHE A 109
VAL A  47
ILE A  51
PHE A  79
None
1.42A 3vawA-1i4sA:
undetectable
3vawA-1i4sA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jvw MACROPHAGE
INFECTIVITY
POTENTIATOR


(Trypanosoma
cruzi)
PF00254
(FKBP_C)
6 PHE A 114
ILE A 120
TRP A 123
TYR A 146
ILE A 155
PHE A 163
None
1.01A 3vawA-1jvwA:
16.2
3vawA-1jvwA:
27.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jvw MACROPHAGE
INFECTIVITY
POTENTIATOR


(Trypanosoma
cruzi)
PF00254
(FKBP_C)
8 TYR A  92
ARG A 108
VAL A 119
ILE A 120
TRP A 123
TYR A 146
ILE A 155
PHE A 163
None
0.45A 3vawA-1jvwA:
16.2
3vawA-1jvwA:
27.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jvw MACROPHAGE
INFECTIVITY
POTENTIATOR


(Trypanosoma
cruzi)
PF00254
(FKBP_C)
8 TYR A  92
ASP A 103
ARG A 108
ILE A 120
TRP A 123
TYR A 146
ILE A 155
PHE A 163
None
0.67A 3vawA-1jvwA:
16.2
3vawA-1jvwA:
27.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k1x 4-ALPHA-GLUCANOTRANS
FERASE


(Thermococcus
litoralis)
PF03065
(Glyco_hydro_57)
PF09094
(DUF1925)
PF09095
(DUF1926)
5 TYR A 356
PHE A 317
ILE A  93
ARG A 338
ILE A 347
None
1.39A 3vawA-1k1xA:
undetectable
3vawA-1k1xA:
15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kt1 FK506-BINDING
PROTEIN FKBP51


(Saimiri
boliviensis)
PF00254
(FKBP_C)
PF00515
(TPR_1)
PF13181
(TPR_8)
7 TYR A  57
PHE A  77
VAL A  86
ILE A  87
TRP A  90
TYR A 113
PHE A 130
None
0.81A 3vawA-1kt1A:
15.4
3vawA-1kt1A:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lnl HEMOCYANIN

(Rapana venosa)
PF00264
(Tyrosinase)
PF14830
(Haemocyan_bet_s)
5 ASP A 101
ARG A   8
PHE A 106
VAL A 188
ILE A 140
None
1.30A 3vawA-1lnlA:
undetectable
3vawA-1lnlA:
20.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1n1a FKBP52

(Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  57
ASP A  68
PHE A  77
VAL A  86
ILE A  87
TRP A  90
TYR A 113
ILE A 122
PHE A 130
None
0.58A 3vawA-1n1aA:
18.4
3vawA-1n1aA:
35.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pbk FKBP25

(Homo sapiens)
PF00254
(FKBP_C)
8 TYR A 135
ASP A 146
VAL A 171
ILE A 172
TRP A 175
TYR A 198
ILE A 208
PHE A 216
RAP  A 225 (-3.9A)
RAP  A 225 (-3.0A)
RAP  A 225 (-3.5A)
RAP  A 225 (-3.9A)
RAP  A 225 (-3.4A)
RAP  A 225 (-4.6A)
RAP  A 225 ( 4.9A)
None
0.32A 3vawA-1pbkA:
17.4
3vawA-1pbkA:
26.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q6h FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKPA


(Escherichia
coli)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
6 PHE A 168
ILE A 174
TRP A 177
TYR A 200
ILE A 208
PHE A 216
None
1.28A 3vawA-1q6hA:
18.0
3vawA-1q6hA:
34.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q6h FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKPA


(Escherichia
coli)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
9 TYR A 146
ASP A 157
ARG A 162
VAL A 173
ILE A 174
TRP A 177
TYR A 200
ILE A 208
PHE A 216
None
0.54A 3vawA-1q6hA:
18.0
3vawA-1q6hA:
34.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1r9h FK506 BINDING
PROTEIN FAMILY


(Caenorhabditis
elegans)
PF00254
(FKBP_C)
10 TYR A  40
ASP A  51
ARG A  56
PHE A  60
VAL A  69
ILE A  70
TRP A  73
TYR A  96
ILE A 105
PHE A 113
None
0.61A 3vawA-1r9hA:
19.5
3vawA-1r9hA:
31.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rc7 RIBONUCLEASE III

(Aquifex
aeolicus)
PF00035
(dsrm)
PF14622
(Ribonucleas_3_3)
5 ASP A 138
PHE A 109
VAL A  47
ILE A  51
PHE A  79
None
1.36A 3vawA-1rc7A:
undetectable
3vawA-1rc7A:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ry2 ACETYL-COENZYME A
SYNTHETASE 1


(Saccharomyces
cerevisiae)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
PF16177
(ACAS_N)
5 PHE A 349
VAL A 466
ILE A 465
TYR A 454
ILE A 458
None
1.07A 3vawA-1ry2A:
undetectable
3vawA-1ry2A:
15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sa3 TYPE II RESTRICTION
ENZYME MSPI


(Moraxella sp.)
PF09208
(Endonuc-MspI)
5 TYR A 214
ASP A 216
ILE A  38
ILE A 219
PHE A 207
None
1.40A 3vawA-1sa3A:
undetectable
3vawA-1sa3A:
19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u79 FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
3


(Arabidopsis
thaliana)
PF00254
(FKBP_C)
8 TYR A  37
ASP A  48
VAL A  66
ILE A  67
TRP A  70
TYR A  99
ILE A 113
PHE A 121
None
0.47A 3vawA-1u79A:
19.7
3vawA-1u79A:
29.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x3w PEPTIDE:N-GLYCANASE

(Saccharomyces
cerevisiae)
PF03835
(Rad4)
5 ASP A 242
ARG A 230
VAL A 212
TYR A 247
ILE A 246
None
None
None
None
SUC  A1002 (-4.5A)
1.38A 3vawA-1x3wA:
undetectable
3vawA-1x3wA:
16.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1yat FK506 BINDING
PROTEIN


(Saccharomyces
cerevisiae)
PF00254
(FKBP_C)
10 TYR A  26
ASP A  37
ARG A  42
PHE A  46
VAL A  55
ILE A  56
TRP A  59
TYR A  82
ILE A  91
PHE A  99
FK5  A 108 ( 4.0A)
FK5  A 108 ( 3.3A)
FK5  A 108 (-3.7A)
FK5  A 108 ( 4.0A)
FK5  A 108 ( 3.4A)
FK5  A 108 ( 3.7A)
FK5  A 108 ( 3.6A)
FK5  A 108 ( 4.7A)
None
None
0.26A 3vawA-1yatA:
20.1
3vawA-1yatA:
34.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cxe RIBULOSE
BISPHOSPHATE
CARBOXYLASE


(Pyrococcus
horikoshii)
PF00016
(RuBisCO_large)
PF02788
(RuBisCO_large_N)
5 VAL A 249
ILE A 225
TYR A 207
ARG A 210
PHE A 199
None
1.23A 3vawA-2cxeA:
undetectable
3vawA-2cxeA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gh4 PUTATIVE GLYCOSYL
HYDROLASE YTER


(Bacillus
subtilis)
PF07470
(Glyco_hydro_88)
5 TYR A 285
ASP A 224
ARG A  52
TYR A 295
ILE A 226
None
1.29A 3vawA-2gh4A:
undetectable
3vawA-2gh4A:
19.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2lpv FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Aedes aegypti)
PF00254
(FKBP_C)
5 TYR A  27
PHE A  47
ILE A  57
TRP A  60
ILE A  92
None
1.03A 3vawA-2lpvA:
14.3
3vawA-2lpvA:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2lpv FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Aedes aegypti)
PF00254
(FKBP_C)
5 TYR A  27
VAL A  56
ILE A  57
TRP A  60
ILE A  92
None
0.98A 3vawA-2lpvA:
14.3
3vawA-2lpvA:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2pbc FK506-BINDING
PROTEIN 2


(Homo sapiens)
PF00254
(FKBP_C)
6 PHE A  78
ILE A  86
TRP A  89
TYR A 112
ILE A 121
PHE A 129
None
PEG  A 201 (-3.8A)
PEG  A 201 (-3.7A)
None
None
None
1.47A 3vawA-2pbcA:
15.8
3vawA-2pbcA:
33.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2pbc FK506-BINDING
PROTEIN 2


(Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  56
ASP A  67
PHE A  76
VAL A  85
ILE A  86
TRP A  89
TYR A 112
ILE A 121
PHE A 129
PEG  A 201 (-4.4A)
None
PEG  A 201 ( 3.9A)
PEG  A 201 (-3.6A)
PEG  A 201 (-3.8A)
PEG  A 201 (-3.7A)
None
None
None
0.77A 3vawA-2pbcA:
15.8
3vawA-2pbcA:
33.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vcd OUTER MEMBRANE
PROTEIN MIP


(Legionella
pneumophila)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
5 ASP A  66
VAL A  82
ILE A  83
TRP A  86
PHE A 126
RAP  A 138 (-2.7A)
RAP  A 138 (-3.2A)
RAP  A 138 (-3.6A)
RAP  A 138 (-2.3A)
RAP  A 138 ( 4.7A)
0.76A 3vawA-2vcdA:
15.0
3vawA-2vcdA:
26.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vcd OUTER MEMBRANE
PROTEIN MIP


(Legionella
pneumophila)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
5 TYR A  55
ASP A  66
VAL A  82
ILE A  83
TRP A  86
RAP  A 138 (-2.6A)
RAP  A 138 (-2.7A)
RAP  A 138 (-3.2A)
RAP  A 138 (-3.6A)
RAP  A 138 (-2.3A)
0.74A 3vawA-2vcdA:
15.0
3vawA-2vcdA:
26.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vcd OUTER MEMBRANE
PROTEIN MIP


(Legionella
pneumophila)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
5 TYR A  55
VAL A  82
ILE A  83
TRP A  86
TYR A 109
RAP  A 138 (-2.6A)
RAP  A 138 (-3.2A)
RAP  A 138 (-3.6A)
RAP  A 138 (-2.3A)
RAP  A 138 (-3.8A)
0.62A 3vawA-2vcdA:
15.0
3vawA-2vcdA:
26.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn1 70 KDA
PEPTIDYLPROLYL
ISOMERASE


(Plasmodium
falciparum)
PF00254
(FKBP_C)
10 TYR A  44
ASP A  56
ARG A  61
PHE A  65
VAL A  74
ILE A  75
TRP A  78
TYR A 101
ILE A 110
PHE A 118
FK5  A 501 (-4.1A)
FK5  A 501 (-3.4A)
FK5  A 501 (-3.9A)
FK5  A 501 (-4.1A)
FK5  A 501 (-3.5A)
FK5  A 501 (-4.3A)
FK5  A 501 (-3.3A)
FK5  A 501 (-4.7A)
None
FK5  A 501 (-4.8A)
0.28A 3vawA-2vn1A:
19.5
3vawA-2vn1A:
29.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y78 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
9 TYR A  33
ARG A  49
PHE A  53
VAL A  62
ILE A  63
TRP A  66
TYR A  89
ILE A  98
PHE A 106
None
0.48A 3vawA-2y78A:
22.1
3vawA-2y78A:
59.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y78 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
9 TYR A  33
ASP A  44
ARG A  49
PHE A  53
ILE A  63
TRP A  66
TYR A  89
ILE A  98
PHE A 106
None
0.64A 3vawA-2y78A:
22.1
3vawA-2y78A:
59.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b05 ISOPENTENYL-DIPHOSPH
ATE DELTA-ISOMERASE


(Sulfolobus
shibatae)
PF01070
(FMN_dh)
5 ASP A 150
ARG A 114
VAL A  64
ILE A 191
PHE A  53
None
1.33A 3vawA-3b05A:
undetectable
3vawA-3b05A:
21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b7x FK506-BINDING
PROTEIN 6


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  61
ASP A  73
TYR A 118
ILE A 127
PHE A 135
None
0.99A 3vawA-3b7xA:
15.5
3vawA-3b7xA:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3clo TRANSCRIPTIONAL
REGULATOR


(Bacteroides
thetaiotaomicron)
PF00196
(GerE)
5 ASP A  82
PHE A 106
VAL A 142
TYR A 160
ILE A  86
None
1.35A 3vawA-3cloA:
undetectable
3vawA-3cloA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3foc TRYPTOPHANYL-TRNA
SYNTHETASE


(Giardia
intestinalis)
PF00579
(tRNA-synt_1b)
5 ASP A 208
ARG A 214
PHE A 212
VAL A 106
TYR A 155
None
1.24A 3vawA-3focA:
undetectable
3vawA-3focA:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i9f PUTATIVE TYPE 11
METHYLTRANSFERASE


(Sulfolobus
solfataricus)
PF08241
(Methyltransf_11)
5 TYR A 147
ASP A 126
PHE A 151
VAL A 122
ILE A 123
None
1.32A 3vawA-3i9fA:
undetectable
3vawA-3i9fA:
21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ibp CHROMOSOME PARTITION
PROTEIN MUKB


(Escherichia
coli)
PF16330
(MukB_hinge)
5 TYR A 690
ASP A 746
PHE A 778
ILE A 737
PHE A 744
None
1.41A 3vawA-3ibpA:
undetectable
3vawA-3ibpA:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j9d OUTER CAPSID PROTEIN
VP2


(Bluetongue
virus)
PF00898
(Orbi_VP2)
5 ARG A 685
VAL A 712
ILE A 701
TYR A 745
ILE A 674
None
1.33A 3vawA-3j9dA:
undetectable
3vawA-3j9dA:
11.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j9d OUTER CAPSID PROTEIN
VP2


(Bluetongue
virus)
PF00898
(Orbi_VP2)
5 ASP A 679
VAL A 712
ILE A 701
TYR A 745
ILE A 674
None
1.39A 3vawA-3j9dA:
undetectable
3vawA-3j9dA:
11.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mm5 SULFITE REDUCTASE,
DISSIMILATORY-TYPE
SUBUNIT ALPHA


(Archaeoglobus
fulgidus)
PF01077
(NIR_SIR)
PF03460
(NIR_SIR_ferr)
5 ILE A 347
TRP A 348
ARG A 379
ILE A 309
PHE A 212
None
1.39A 3vawA-3mm5A:
undetectable
3vawA-3mm5A:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mm5 SULFITE REDUCTASE,
DISSIMILATORY-TYPE
SUBUNIT ALPHA


(Archaeoglobus
fulgidus)
PF01077
(NIR_SIR)
PF03460
(NIR_SIR_ferr)
5 TYR A 199
ILE A 347
TRP A 348
ARG A 379
ILE A 309
None
1.45A 3vawA-3mm5A:
undetectable
3vawA-3mm5A:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n11 CHITINASE A

(Bacillus cereus)
PF00704
(Glyco_hydro_18)
5 TYR A  82
PHE A  88
VAL A  64
ILE A  62
TRP A  40
None
1.43A 3vawA-3n11A:
undetectable
3vawA-3n11A:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5d PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  57
ASP A  68
PHE A  77
VAL A  86
ILE A  87
TRP A  90
TYR A 113
ILE A 122
PHE A 130
None
0.82A 3vawA-3o5dA:
15.4
3vawA-3o5dA:
24.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o5e PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
8 TYR A  57
ASP A  68
PHE A  77
VAL A  86
ILE A  87
TYR A 113
ILE A 122
PHE A 130
None
0.80A 3vawA-3o5eA:
18.9
3vawA-3o5eA:
31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o5e PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
8 TYR A  57
PHE A  77
VAL A  86
ILE A  87
TRP A  90
TYR A 113
ILE A 122
PHE A 130
None
0.79A 3vawA-3o5eA:
18.9
3vawA-3o5eA:
31.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pa7 70 KDA
PEPTIDYLPROLYL
ISOMERASE, PUTATIVE


(Plasmodium
vivax)
PF00254
(FKBP_C)
9 TYR A  43
ARG A  60
PHE A  64
VAL A  73
ILE A  74
TRP A  77
TYR A 100
ILE A 109
PHE A 117
None
0.46A 3vawA-3pa7A:
19.5
3vawA-3pa7A:
28.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pa7 70 KDA
PEPTIDYLPROLYL
ISOMERASE, PUTATIVE


(Plasmodium
vivax)
PF00254
(FKBP_C)
9 TYR A  43
ASP A  55
ARG A  60
PHE A  64
VAL A  73
ILE A  74
TRP A  77
ILE A 109
PHE A 117
None
0.63A 3vawA-3pa7A:
19.5
3vawA-3pa7A:
28.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sqw ATP-DEPENDENT RNA
HELICASE MSS116,
MITOCHONDRIAL


(Saccharomyces
cerevisiae)
PF00270
(DEAD)
PF00271
(Helicase_C)
5 ASP A 343
VAL A 498
ILE A 497
TYR A 460
ILE A 464
None
1.04A 3vawA-3sqwA:
undetectable
3vawA-3sqwA:
15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3um6 BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Plasmodium
falciparum)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
5 TYR A 569
VAL A 210
ILE A 224
TYR A 226
ILE A 200
None
1.27A 3vawA-3um6A:
undetectable
3vawA-3um6A:
13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bf8 FPR4

(Saccharomyces
cerevisiae)
PF00254
(FKBP_C)
7 ASP A 324
VAL A 341
ILE A 342
TRP A 345
TYR A 368
ILE A 376
PHE A 384
None
0.76A 3vawA-4bf8A:
17.9
3vawA-4bf8A:
28.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bf8 FPR4

(Saccharomyces
cerevisiae)
PF00254
(FKBP_C)
6 TYR A 313
ASP A 324
PHE A 332
ILE A 342
TRP A 345
PHE A 384
None
0.96A 3vawA-4bf8A:
17.9
3vawA-4bf8A:
28.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bf8 FPR4

(Saccharomyces
cerevisiae)
PF00254
(FKBP_C)
7 TYR A 313
ASP A 324
VAL A 341
ILE A 342
TRP A 345
TYR A 368
PHE A 384
None
0.78A 3vawA-4bf8A:
17.9
3vawA-4bf8A:
28.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckm SAS-6

(Leishmania
major)
PF16531
(SAS-6_N)
5 TYR A 196
PHE A 209
VAL A 173
ILE A 263
PHE A 199
None
1.34A 3vawA-4ckmA:
undetectable
3vawA-4ckmA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4db4 ATP-DEPENDENT RNA
HELICASE MSS116,
MITOCHONDRIAL


(Saccharomyces
cerevisiae)
PF00271
(Helicase_C)
5 ASP A 343
VAL A 498
ILE A 497
TYR A 460
ILE A 464
None
1.08A 3vawA-4db4A:
undetectable
3vawA-4db4A:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dip PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP14


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  52
TRP A  88
TYR A 111
ILE A 119
PHE A 127
None
0.63A 3vawA-4dipA:
17.2
3vawA-4dipA:
28.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4dz3 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
10 TYR A  33
ASP A  44
ARG A  49
PHE A  53
VAL A  62
ILE A  63
TRP A  66
TYR A  89
ILE A  98
PHE A 106
FK5  A 201 ( 3.9A)
FK5  A 201 (-3.5A)
FK5  A 201 ( 3.7A)
FK5  A 201 (-4.1A)
FK5  A 201 ( 3.6A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.4A)
FK5  A 201 (-4.7A)
None
FK5  A 201 (-4.8A)
0.24A 3vawA-4dz3A:
22.8
3vawA-4dz3A:
98.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h09 HYPOTHETICAL LEUCINE
RICH REPEAT PROTEIN


(Eubacterium
ventriosum)
PF13306
(LRR_5)
5 PHE A 337
VAL A 346
ILE A 369
ILE A 375
PHE A 383
None
1.32A 3vawA-4h09A:
undetectable
3vawA-4h09A:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hl7 NICOTINATE
PHOSPHORIBOSYLTRANSF
ERASE


(Vibrio cholerae)
PF04095
(NAPRTase)
5 ASP A 303
ARG A 342
PHE A 321
ILE A 273
TRP A 301
None
1.44A 3vawA-4hl7A:
undetectable
3vawA-4hl7A:
18.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4iqc PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1B


(Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  26
ASP A  37
ARG A  42
ILE A  56
TYR A  82
ILE A  91
PHE A  99
None
0.77A 3vawA-4iqcA:
17.5
3vawA-4iqcA:
30.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4iqc PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1B


(Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  26
PHE A  46
VAL A  55
ILE A  56
TYR A  82
ILE A  91
PHE A  99
None
0.77A 3vawA-4iqcA:
17.5
3vawA-4iqcA:
30.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iyk UNCHARACTERIZED
PROTEIN


(Bacteroides
uniformis)
PF12866
(DUF3823)
5 VAL A 111
ILE A  30
TYR A  76
ILE A  53
PHE A 103
None
1.37A 3vawA-4iykA:
undetectable
3vawA-4iykA:
23.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4law PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4


(Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  57
ARG A  73
PHE A  77
VAL A  86
ILE A  87
TRP A  90
TYR A 113
ILE A 122
PHE A 130
None
None
None
DMS  A 304 (-3.5A)
DMS  A 304 (-3.8A)
DMS  A 304 ( 4.0A)
None
None
DMS  A 304 (-4.3A)
0.76A 3vawA-4lawA:
15.7
3vawA-4lawA:
24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4law PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4


(Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  57
ASP A  68
ARG A  73
PHE A  77
VAL A  86
ILE A  87
TRP A  90
ILE A 122
PHE A 130
None
None
None
None
DMS  A 304 (-3.5A)
DMS  A 304 (-3.8A)
DMS  A 304 ( 4.0A)
None
DMS  A 304 (-4.3A)
0.83A 3vawA-4lawA:
15.7
3vawA-4lawA:
24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4msp PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP14


(Homo sapiens)
PF00254
(FKBP_C)
PF13499
(EF-hand_7)
5 TYR A  33
TRP A  69
TYR A  92
ILE A 100
PHE A 108
None
0.57A 3vawA-4mspA:
17.9
3vawA-4mspA:
26.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nnr PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP2


(Homo sapiens)
PF00254
(FKBP_C)
10 TYR A  56
ASP A  67
PHE A  76
VAL A  85
ILE A  86
TRP A  89
TYR A 112
ARG A 115
ILE A 121
PHE A 129
FK5  A 201 (-4.1A)
FK5  A 201 (-3.4A)
FK5  A 201 (-4.0A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.5A)
FK5  A 201 (-4.5A)
FK5  A 201 (-4.2A)
None
FK5  A 201 (-4.9A)
0.60A 3vawA-4nnrA:
13.2
3vawA-4nnrA:
34.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4odm PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD


(Thermus
thermophilus)
PF00254
(FKBP_C)
5 TYR A  13
ASP A  23
ILE A  37
TYR A  63
PHE A 128
None
0.52A 3vawA-4odmA:
11.0
3vawA-4odmA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4odr PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD,
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A CHIMERA


(Homo sapiens;
Thermus
thermophilus)
PF00254
(FKBP_C)
6 TYR A  13
ASP A  23
ILE A  37
TYR A  63
ILE A  72
PHE A  80
FK5  A 201 ( 3.6A)
FK5  A 201 (-3.6A)
FK5  A 201 (-3.9A)
FK5  A 201 (-4.4A)
None
FK5  A 201 ( 4.8A)
0.43A 3vawA-4odrA:
11.5
3vawA-4odrA:
18.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4r0x PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  57
ARG A  73
PHE A  77
VAL A  86
ILE A  87
TRP A  90
TYR A 113
ILE A 122
PHE A 130
None
0.78A 3vawA-4r0xA:
19.7
3vawA-4r0xA:
31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4r0x PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  57
ASP A  68
ARG A  73
PHE A  77
VAL A  86
ILE A  87
TYR A 113
ILE A 122
PHE A 130
None
0.88A 3vawA-4r0xA:
19.7
3vawA-4r0xA:
31.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4sli INTRAMOLECULAR
TRANS-SIALIDASE


(Macrobdella
decora)
PF02973
(Sialidase)
PF13088
(BNR_2)
5 VAL A 526
ILE A 525
TYR A 457
ILE A 434
PHE A 409
None
1.42A 3vawA-4sliA:
undetectable
3vawA-4sliA:
16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ukd URIDYLMONOPHOSPHATE/
CYTIDYLMONOPHOSPHATE
KINASE


(Dictyostelium
discoideum)
PF00406
(ADK)
5 ASP A 184
ARG A 176
PHE A 117
ILE A  26
ARG A  28
None
1.35A 3vawA-4ukdA:
undetectable
3vawA-4ukdA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z7l CAS6B

(Methanococcus
maripaludis)
PF17262
(DUF5328)
5 TYR A  31
ILE A  63
TYR A  10
ILE A  94
PHE A  27
None
1.30A 3vawA-4z7lA:
undetectable
3vawA-4z7lA:
25.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zmh UNCHARACTERIZED
PROTEIN


(Saccharophagus
degradans)
PF15979
(Glyco_hydro_115)
5 ASP A 944
PHE A 845
ILE A 840
TYR A 459
ARG A 417
None
1.00A 3vawA-4zmhA:
undetectable
3vawA-4zmhA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zmh UNCHARACTERIZED
PROTEIN


(Saccharophagus
degradans)
PF15979
(Glyco_hydro_115)
5 ASP A 944
PHE A 845
ILE A 840
TYR A 459
ILE A 883
None
1.05A 3vawA-4zmhA:
undetectable
3vawA-4zmhA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b2o CRISPR-ASSOCIATED
ENDONUCLEASE CAS9


(Francisella
tularensis)
no annotation 5 PHE A1576
VAL A1561
ILE A1547
TYR A1549
ILE A1611
None
1.25A 3vawA-5b2oA:
undetectable
3vawA-5b2oA:
9.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b8i PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Coccidioides
immitis)
PF00254
(FKBP_C)
10 TYR C  36
ASP C  56
ARG C  61
PHE C  64
VAL C  73
ILE C  74
TRP C  77
TYR C 100
ILE C 109
PHE C 117
FK5  C 201 (-4.1A)
FK5  C 201 ( 3.8A)
FK5  C 201 (-3.8A)
FK5  C 201 (-3.8A)
FK5  C 201 (-3.5A)
FK5  C 201 (-3.8A)
FK5  C 201 (-3.4A)
FK5  C 201 (-4.5A)
None
FK5  C 201 (-4.7A)
0.45A 3vawA-5b8iC:
17.0
3vawA-5b8iC:
28.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i7p PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A,FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD,PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A


(Escherichia
coli;
Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  26
ASP A  37
ARG A  42
PHE A  46
VAL A  55
ILE A  56
TRP A  59
TYR A  82
PHE A 146
None
0.60A 3vawA-5i7pA:
16.3
3vawA-5i7pA:
24.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i7q PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A,FKBP-TYPE 16
KDA PEPTIDYL-PROLYL
CIS-TRANS
ISOMERASE,PEPTIDYL-P
ROLYL CIS-TRANS
ISOMERASE FKBP1A


(Escherichia
coli;
Homo sapiens)
PF00254
(FKBP_C)
9 TYR A  26
ASP A  37
ARG A  42
PHE A  46
VAL A  55
ILE A  56
TRP A  59
TYR A  82
PHE A 147
None
0.56A 3vawA-5i7qA:
16.6
3vawA-5i7qA:
26.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i98 FK506-BINDING
PROTEIN 1


(Candida
albicans)
PF00254
(FKBP_C)
7 ASP A  41
ARG A  46
PHE A  50
VAL A  59
ILE A  60
TYR A  97
ILE A 102
None
1.42A 3vawA-5i98A:
17.3
3vawA-5i98A:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i98 FK506-BINDING
PROTEIN 1


(Candida
albicans)
PF00254
(FKBP_C)
10 TYR A  30
ASP A  41
ARG A  46
PHE A  50
VAL A  59
ILE A  60
TRP A  63
TYR A  97
ILE A 106
PHE A 114
None
0.61A 3vawA-5i98A:
17.3
3vawA-5i98A:
30.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5j6e FK506-BINDING
PROTEIN 1A


(Aspergillus
fumigatus)
PF00254
(FKBP_C)
10 TYR A  27
ASP A  38
ARG A  43
PHE A  47
VAL A  56
ILE A  57
TRP A  60
TYR A  83
ILE A  92
PHE A 100
None
0.62A 3vawA-5j6eA:
18.4
3vawA-5j6eA:
31.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jcv LMO2181 PROTEIN

(Listeria
monocytogenes)
PF04203
(Sortase)
5 ASP A 125
VAL A  75
ILE A  89
TYR A 161
ILE A 221
None
1.04A 3vawA-5jcvA:
undetectable
3vawA-5jcvA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jvk UNCHARACTERIZED
PROTEIN


(Bacteroides
cellulosilyticus)
no annotation 5 ASP A 162
VAL A 134
ILE A 159
ILE A 197
PHE A 184
GOL  A 654 (-2.9A)
None
None
None
None
1.43A 3vawA-5jvkA:
undetectable
3vawA-5jvkA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l1b GLUTAMATE RECEPTOR
2,GLUTAMATE RECEPTOR
2


(Rattus
norvegicus)
PF00060
(Lig_chan)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd)
5 ASP A 138
ARG A 141
VAL A 205
TYR A 177
ILE A 168
None
1.43A 3vawA-5l1bA:
undetectable
3vawA-5l1bA:
14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m99 ALPHA-AMYLASE

(Thermotoga
petrophila)
PF00128
(Alpha-amylase)
5 ASP B 213
VAL B 195
ILE B 198
TYR B  88
ILE B  85
EDO  B 616 ( 2.8A)
None
None
None
None
1.29A 3vawA-5m99B:
undetectable
3vawA-5m99B:
18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5msz THERMOBIA DOMESTICA
DOMESTICA AA15


(Thermobia
domestica)
no annotation 5 ASP A  84
VAL A  72
ILE A 190
TYR A  75
ILE A  81
None
1.12A 3vawA-5mszA:
undetectable
3vawA-5mszA:
16.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5v8t UBIQUITIN-LIKE
PROTEIN
SMT3,PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei;
Saccharomyces
cerevisiae)
no annotation 10 TYR A  33
ASP A  44
ARG A  49
PHE A  53
VAL A  62
ILE A  63
TRP A  66
TYR A  89
ILE A  98
PHE A 106
8ZV  A 201 (-3.8A)
8ZV  A 201 (-3.9A)
8ZV  A 201 (-3.6A)
8ZV  A 201 (-3.9A)
8ZV  A 201 (-3.6A)
8ZV  A 201 (-4.0A)
8ZV  A 201 (-3.3A)
8ZV  A 201 (-4.6A)
8ZV  A 201 ( 4.8A)
8ZV  A 201 (-4.6A)
0.37A 3vawA-5v8tA:
27.6
3vawA-5v8tA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vf3 MAJOR CAPSID PROTEIN

(Escherichia
virus T4)
PF07068
(Gp23)
5 TYR A 424
ASP A 110
VAL A 307
ILE A 310
PHE A 375
None
1.40A 3vawA-5vf3A:
undetectable
3vawA-5vf3A:
19.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xb0 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Pseudomonas
syringae group
genomosp. 3)
PF00254
(FKBP_C)
6 PHE A 166
ILE A 172
TRP A 175
TYR A 198
ILE A 207
PHE A 215
TLA  A 301 ( 4.6A)
TLA  A 301 (-3.4A)
TLA  A 301 (-3.4A)
None
None
None
1.16A 3vawA-5xb0A:
15.7
3vawA-5xb0A:
32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xb0 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Pseudomonas
syringae group
genomosp. 3)
PF00254
(FKBP_C)
8 TYR A 147
ASP A 158
VAL A 171
ILE A 172
TRP A 175
TYR A 198
ILE A 207
PHE A 215
TLA  A 301 ( 4.4A)
TLA  A 301 (-3.7A)
TLA  A 301 (-3.4A)
TLA  A 301 (-3.4A)
TLA  A 301 (-3.4A)
None
None
None
0.74A 3vawA-5xb0A:
15.7
3vawA-5xb0A:
32.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xhw PUTATIVE
6-DEOXY-D-MANNOHEPTO
SE PATHWAY PROTEIN


(Yersinia
pseudotuberculosis)
no annotation 5 TYR A 207
VAL A 132
ILE A 165
TYR A 140
ILE A 213
None
1.40A 3vawA-5xhwA:
undetectable
3vawA-5xhwA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y31 DISINTEGRIN AND
METALLOPROTEINASE
DOMAIN-CONTAINING
PROTEIN 22


(Homo sapiens)
no annotation 5 PHE A 330
VAL A 270
ILE A 285
TYR A 277
ILE A 378
None
1.23A 3vawA-5y31A:
undetectable
3vawA-5y31A:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5z0y SERINE
HYDROXYMETHYLTRANSFE
RASE


(Komagataella
phaffii)
no annotation 5 TYR A 339
ASP A 418
VAL A 393
ILE A 395
PHE A 334
None
1.29A 3vawA-5z0yA:
undetectable
3vawA-5z0yA:
21.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6b4p PEPTIDYLPROLYL
ISOMERASE


(Naegleria
fowleri)
no annotation 10 TYR A  38
ASP A  49
ARG A  54
PHE A  58
VAL A  67
ILE A  68
TRP A  71
TYR A  94
ILE A 103
PHE A 111
None
0.61A 3vawA-6b4pA:
19.1
3vawA-6b4pA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bsz METABOTROPIC
GLUTAMATE RECEPTOR 8


(Homo sapiens)
no annotation 5 TYR A 344
ASP A  84
ARG A 355
VAL A 402
ILE A 406
None
1.23A 3vawA-6bszA:
undetectable
3vawA-6bszA:
16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ez4 RNA POLYMERASE
II-ASSOCIATED
PROTEIN 3


(Homo sapiens)
no annotation 5 VAL A 595
ILE A 594
TYR A 578
ILE A 573
PHE A 556
None
1.36A 3vawA-6ez4A:
undetectable
3vawA-6ez4A:
16.50